1. GISSI-2: A factorial randomized trial of anteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Gruppo Italiano per lo Sopravvivenza nell'Infarcto Miocardico;Lancet,1990
2. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico GISSI;Lancet,1986
3. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction;ISIS Second International Study of Infarct Survival Collaborative Group;Lancet,1988
4. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET);Wilcox;Lancet,1988
5. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo controlled clinical trial;AIMS Trial Study Group;Lancet,1988